Total Marrow and Lymphoid Irradiation (TMLI) at a Dose of 2000cGy in Combination with Post-Transplant Cyclophosphamide (PTCy)-Based Graft Versus Host Disease (GvHD) Prophylaxis Is Safe and Associated with Favorable GvHD-Free/Relapse-Free Survival at 1 Year in Patients with Acute Myeloid Leukemia (AML)

Anthony S Stein,Joseph Rosenthal,Amandeep Salhotra,Ryotaro Nakamura,Monzr M Al Malki,Ibrahim Aldoss,Stephen J Forman,Joycelynne Palmer,Haris Ali,Ahmed Aribi,Ricardo Spielberger,Chatchada Karanes,Len Farol,Andrew S Artz,Guido Marcucci,Dongyun Yang,David S Snyder ,Eric H Radany ,Samer K Khaled ,James F Sanchez ,Ni‐Chun Tsai ,Lê Văn An ,Hui Song ,Vinod Pullarkat ,Jeffrey Y.c Wong

doi:10.1182/blood-2020-141469

Total Marrow and Lymphoid Irradiation (TMLI) at a Dose of 2000cGy in Combination with Post-Transplant Cyclophosphamide (PTCy)-Based Graft Versus Host Disease (GvHD) Prophylaxis Is Safe and Associated with Favorable GvHD-Free/Relapse-Free Survival at 1 Year in Patients with Acute Myeloid Leukemia (AML)

Anthony S Stein, Joseph Rosenthal + Show 23 more

Open Access

https://doi.org/10.1182/blood-2020-141469

Copy DOI

Journal: Blood	Publication Date: Nov 5, 2020
Citations: 3

Affiliation: City of Hope, City Of Hope National Medical Center, Kaiser Permanente

#Total Marrow And Lymphoid Irradiation #Speakers Bureau + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Total Marrow and Lymphoid Irradiation (TMLI) at a Dose of 2000cGy in Combination with Post-Transplant Cyclophosphamide (PTCy)-Based Graft Versus Host Disease (GvHD) Prophylaxis Is Safe and Associated with Favorable GvHD-Free/Relapse-Free Survival at 1 Year in Patients with Acute Myeloid Leukemia (AML)

Full Text